TrialGenetic testing and molecular biomarkers2011

Willingness to pay for genetic testing for Alzheimer's disease: a measure of personal utility.

Ilona M Kopits et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.